• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.15% Nasdaq Up 0.36%

    More On BLRX

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    Financials

    BioLineRx, Ltd. (BLRX)

    -NasdaqCM
    1.72 Up 0.03(1.78%) Dec 19, 4:00PM EST
    Add to Portfolio
    Prev Close:1.69
    Open:1.71
    Bid:N/A
    Ask:1.90 x 500
    1y Target Est:8.50
    Beta:1.92
    Next Earnings Date:N/A
    Day's Range:1.68 - 1.75
    52wk Range:1.20 - 3.12
    Volume:128,698
    Avg Vol (3m):173,498
    Market Cap:58.68M
    P/E (ttm):N/A
    EPS (ttm):-0.34
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for BLRX

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.45
    Quarterly EPS Est (Sep-14) :-0.17
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    BioLineRx Ltd., a clinical stage biopharmaceutical development company, is engaged in identifying, in-licensing, and developing therapeutic candidates that address unmet medical needs. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback